NCT04262466 2026-03-06Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsImmunocore LtdPhase 1/2 Active not recruiting410 enrolled
NCT06596473 2026-03-05A Study of BG-C477 in Participants With Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting310 enrolled
NCT05981703 2026-03-04A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting217 enrolled